| Primary |
| Hiv Infection |
39.7% |
| Drug Use For Unknown Indication |
15.7% |
| Drug Exposure During Pregnancy |
12.4% |
| Product Used For Unknown Indication |
8.6% |
| Maternal Exposure Timing Unspecified |
3.8% |
| Antiretroviral Therapy |
3.7% |
| Prophylaxis |
2.6% |
| Prophylaxis Against Hiv Infection |
2.2% |
| Antifungal Prophylaxis |
1.6% |
| Maternal Exposure During Pregnancy |
1.6% |
| Hypertension |
1.3% |
| Acquired Immunodeficiency Syndrome |
1.2% |
| Hiv Test Positive |
1.0% |
| Tuberculosis |
0.8% |
| Antiviral Treatment |
0.7% |
| Insomnia |
0.7% |
| Hepatitis C |
0.7% |
| Mycobacterium Avium Complex Infection |
0.6% |
| Antibiotic Prophylaxis |
0.6% |
| Diarrhoea |
0.6% |
|
| Vomiting |
11.4% |
| Drug Exposure During Pregnancy |
9.6% |
| Premature Baby |
8.0% |
| Abortion Spontaneous |
7.8% |
| Pyrexia |
5.9% |
| Weight Decreased |
5.9% |
| Stillbirth |
5.5% |
| Death |
5.2% |
| Foetal Exposure During Pregnancy |
4.7% |
| Abortion Induced |
4.1% |
| Diarrhoea |
4.1% |
| Pneumonia |
3.6% |
| Renal Failure Acute |
3.5% |
| Renal Failure |
3.3% |
| Nausea |
3.1% |
| Unevaluable Event |
3.0% |
| Trisomy 21 |
2.9% |
| Ventricular Septal Defect |
2.9% |
| Gastrointestinal Disorder |
2.9% |
| Rhabdomyolysis |
2.3% |
|
| Secondary |
| Hiv Infection |
59.6% |
| Drug Use For Unknown Indication |
7.8% |
| Antiretroviral Therapy |
5.4% |
| Product Used For Unknown Indication |
4.2% |
| Acquired Immunodeficiency Syndrome |
3.6% |
| Antiviral Treatment |
3.1% |
| Drug Exposure During Pregnancy |
2.9% |
| Prophylaxis |
1.8% |
| Antifungal Prophylaxis |
1.7% |
| Prophylaxis Against Hiv Infection |
1.6% |
| Mycobacterium Avium Complex Infection |
1.2% |
| Antiviral Prophylaxis |
1.2% |
| Insomnia |
1.1% |
| Hypertension |
1.0% |
| Hiv Test Positive |
0.8% |
| Maternal Exposure During Pregnancy |
0.8% |
| Hepatitis C |
0.7% |
| Factor Viii Deficiency |
0.6% |
| Tuberculosis |
0.6% |
| Cytomegalovirus Infection |
0.5% |
|
| Drug Exposure During Pregnancy |
17.5% |
| Vomiting |
11.4% |
| Weight Decreased |
7.4% |
| Pregnancy |
6.6% |
| Maternal Exposure During Pregnancy |
6.2% |
| Premature Baby |
5.5% |
| Stillbirth |
5.0% |
| Renal Failure Acute |
4.6% |
| Abortion Spontaneous |
4.3% |
| Death |
4.1% |
| Myocardial Infarction |
3.6% |
| White Blood Cell Count Decreased |
3.5% |
| Foetal Exposure During Pregnancy |
2.8% |
| Pyrexia |
2.8% |
| Microcephaly |
2.7% |
| Pneumonia |
2.6% |
| Rash |
2.6% |
| Rhabdomyolysis |
2.4% |
| Diabetes Mellitus |
2.2% |
| Thrombocytopenia |
2.2% |
|
| Concomitant |
| Hiv Infection |
65.6% |
| Drug Use For Unknown Indication |
8.1% |
| Product Used For Unknown Indication |
3.3% |
| Drug Exposure During Pregnancy |
3.3% |
| Depression |
2.5% |
| Hepatitis C |
2.0% |
| Acquired Immunodeficiency Syndrome |
1.9% |
| Pain |
1.8% |
| Prophylaxis |
1.5% |
| Tuberculosis |
1.4% |
| Hiv Test Positive |
1.2% |
| Antiretroviral Therapy |
1.2% |
| Hypertension |
1.2% |
| Antifungal Prophylaxis |
0.9% |
| Mycobacterium Avium Complex Infection |
0.8% |
| Factor Viii Deficiency |
0.8% |
| Prophylaxis Against Hiv Infection |
0.7% |
| Neuropathy Peripheral |
0.6% |
| Smoking Cessation Therapy |
0.6% |
| Systemic Antiviral Treatment |
0.6% |
|
| Vomiting |
12.2% |
| Renal Failure Acute |
9.9% |
| Renal Failure |
8.3% |
| Drug Exposure During Pregnancy |
7.6% |
| Stillbirth |
7.3% |
| Abortion Spontaneous |
6.6% |
| Weight Decreased |
5.6% |
| Pyrexia |
4.9% |
| Thrombocytopenia |
4.8% |
| Rash |
3.9% |
| Pregnancy |
3.7% |
| Premature Baby |
3.4% |
| Drug Ineffective |
2.9% |
| Pancreatitis |
2.9% |
| Death |
2.8% |
| Renal Tubular Disorder |
2.8% |
| Tremor |
2.6% |
| Tubulointerstitial Nephritis |
2.6% |
| Ultrasound Antenatal Screen Abnormal |
2.6% |
| Ventricular Septal Defect |
2.6% |
|
| Interacting |
| Hiv Infection |
26.6% |
| Hypertension |
24.5% |
| Drug Use For Unknown Indication |
15.4% |
| Acquired Immunodeficiency Syndrome |
12.6% |
| Product Used For Unknown Indication |
6.7% |
| Chronic Obstructive Pulmonary Disease |
1.5% |
| Schizophrenia, Paranoid Type |
1.5% |
| Convulsion Prophylaxis |
1.3% |
| Headache |
1.3% |
| Myocardial Ischaemia |
1.3% |
| Depression |
1.1% |
| Drug Dependence |
0.9% |
| Hepatitis C Virus |
0.9% |
| Abnormal Behaviour |
0.6% |
| Acute Coronary Syndrome |
0.6% |
| Acute Myocardial Infarction |
0.6% |
| Angina Pectoris |
0.6% |
| Antiretroviral Therapy |
0.6% |
| Asthma |
0.6% |
| Breast Cancer |
0.6% |
|
| Urine Output Decreased |
22.9% |
| Drug Interaction |
21.4% |
| Hypotension |
7.1% |
| Somnolence |
7.1% |
| Overdose |
4.3% |
| Respiratory Disorder |
4.3% |
| Swelling |
4.3% |
| Lipodystrophy Acquired |
2.9% |
| Nystagmus |
2.9% |
| Osteonecrosis |
2.9% |
| Pancytopenia |
2.9% |
| Polyneuropathy |
2.9% |
| Renal Failure Acute |
2.9% |
| Torsade De Pointes |
2.9% |
| Adams-stokes Syndrome |
1.4% |
| Depression |
1.4% |
| Electrocardiogram Qt Prolonged |
1.4% |
| Gastric Ulcer |
1.4% |
| Grand Mal Convulsion |
1.4% |
| Haemoglobin Decreased |
1.4% |
|
